Combating the deathly Coronavirus

Scientists all over the world are on a quest for an antidote since the first patient died from the new coronavirus in summer 2012. Infection Researchers from the German Primate Center have now identified enzymes that activate the virus for infection. The scientists hope that their discovery will contribute to the development of treatment for the life-threatening disease.

The coronavirus 2c EMC/2012 causes severe respiratory disease and . So far more than half of all patients with laboratory confirmed infection died from the disease. The virus presumably originated in the . have revealed a close relationship to viruses in bats. However, it is at present unclear if the new coronavirus was transmitted from bats to humans.

Researchers at the DPZ have investigated the host cell entry of the new coronavirus jointly with colleagues from Hannover, Essen, Bonn and San Francisco. The paper by the first authors Stefanie Gierer and Stephanie Bertram was published online ahead of print by the renowned Journal of Virology.

The ("spike") of the virus attaches to host cells via the newly discovered receptor DPP4 (Raj et al. 2013, Nature) and subsequently the virus enters the cells. The activation of the spike-protein by enzymes, proteases, is a prerequisite to infectious viral entry. The researchers at DPZ have now identified two of these activating proteases, both of which constitute potential targets for intervention. Also, the group demonstrated that a serum derived from an EMC patient can block the spike-mediated entry. This proves that humans are able to generate blocking (so called "neutralizing") antibodies against the virus. For their research the team worked with harmless, artificial virus-like particles ("pseudotypes"), which may now be used as a diagnostic tool for identifying such neutralizing antibodies.

"The human coronavirus EMC is a potential threat to public health," says Stefan Pöhlmann, senior author of the study. "But our research and the research of other groups identified potential targets for intervention and might help to improve our diagnostic tools."

More information: Gierer, S. et al. (2013): The spike-protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2 and is targeted by neutralizing antibodies. Journal of Virology. Epub ahead of print 6 March 2013. doi:10.1128/JVI.00128-13

add to favorites email to friend print save as pdf

Related Stories

Scientists’ studies combat health threats

May 25, 2007

The outbreak of severe acute respiratory syndrome (SARS) in 2002 was a loud wake-up call for researchers studying infectious diseases. SARS infected more than 8,000 people, killed 10 percent of those infected and weakened ...

New coronavirus related to viruses from bats

Nov 20, 2012

The virus that is causing alarm among global public health authorities after it killed a man in Jeddah, Saudi Arabia earlier this year and is now linked to two other cases of disease is a novel type of coronavirus most closely ...

Recommended for you

Ebola in mind, US colleges screen some students

19 hours ago

University students from West Africa may be subject to extra health checks when they arrive to study in the United States as administrators try to insulate their campuses from the worst Ebola outbreak in ...

WHO: More Ebola cases in past week than any other

20 hours ago

The past week has seen the highest increase of Ebola cases since the outbreak in West Africa began, the World Health Organization said Friday, offering more evidence that the crisis is worsening.

User comments